AI-driven drug discovery. New pharmaceuticals are immensely expensive to develop, but that's largely because pharma companies aren't using available data to it

AI-driven drug discovery. New pharmaceuticals are immensely expensive to develop, but that's largely because pharma companies aren't using available data to its full potential. Its never been easier to start a software business, which is bad for most software companies since it means that they'll have no opportunity to create monopolies. AI-driven pharma companies are defensible since their work is much more patentable than a typical software-enabled business, and because they'll benefit from data network-effects in the long term.